scanX
Home
Onyx Biotec

Onyx Biotec

51.00
-1.50
(-2.86%)
search
Market Cap
92.47 Cr
EPS
2.54
PE Ratio
31.44
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
97.45
52 Week Low
48.90
PB Ratio
1.76
Debt to Equity
1.39
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,699.20
#1 4,07,695.00
34.30
#1 49,887.20
12.06
#1 9,648
13.77
39.51
Divis Laboratories
6,089.00
1,61,643.82
76.30
8,184.00
0.89
1,600
#1 64.53
51.01
Cipla
1,518.30
1,22,620.18
24.47
26,520.70
14.17
4,155
47.38
51.85
Torrent Pharmaceuticals
3,221.60
1,09,033.58
58.85
10,785.70
11.59
1,656
13.54
50.18
Mankind Pharma
2,545.00
1,05,001.24
50.48
10,615.60
19.57
1,942
-16.38
54.46
Dr Reddys Laboratories
1,210.60
1,01,019.17
#1 17.64
28,905.40
12.36
5,578
21.14
57.97
Lupin
2,062.00
94,138.74
32.49
20,141.50
#1 19.94
1,936
38.82
50.20
Zydus Life Science
894.55
90,012.66
19.63
19,831.50
13.82
3,831
29.92
51.79
Aurobindo Pharma
1,227.60
71,299.21
19.87
29,559.20
17.55
3,169
-10.04
53.36
Abbott
30,305.00
64,396.01
47.84
6,097.20
10.80
1,201
16.01
48.74
Growth Rate
Revenue Growth
36.11 %
Net Income Growth
66.67 %
Cash Flow Change
-22.45 %
ROE
20.34 %
ROCE
48.45 %
EBITDA Margin (Avg.)
34.69 %

Yearly Financial Results

Annual Financials
2022
2023
2024
TTM
Revenue
45
40
54
0
Expenses
39
35
46
0
EBITDA
6
5
8
0
Operating Profit %
13 %
11 %
15 %
0 %
Depreciation
1
2
2
0
Interest
1
1
2
0
Profit Before Tax
4
3
4
0
Tax
0
1
1
0
Net Profit
3
2
3
0
EPS in ₹
2.84
1.56
2.54
0.00
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
37
59
74
Fixed Assets
17
43
44
Current Assets
14
15
30
Capital Work in Progress
4
0
0
Investments
0
0
0
Other Assets
16
16
31
Total Liabilities
37
59
74
Current Liabilities
10
20
23
Non Current Liabilities
10
20
27
Total Equity
16
18
25
Reserve & Surplus
11
12
12
Share Capital
6
6
13
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
-0
-4
2
Investing Activities
-6
-23
-3
Operating Activities
1
2
2
Financing Activities
5
16
3
Above figures are in Rs. Crores

Share Holding

% Holding
Nov 2024
Mar 2025
Promoter
65.10 %
65.10 %
FIIs
0.00 %
0.00 %
DIIs
0.03 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
18.96 %
18.97 %
Others
15.92 %
15.94 %
No of Share Holders
1,181
551

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 10 Jan 2025 90.15 78.95

Technical Indicators

RSI(14)
Neutral
47.29
ATR(14)
Volatile
2.36
STOCH(9,6)
Neutral
27.91
STOCH RSI(14)
Neutral
48.14
MACD(12,26)
Bullish
0.27
ADX(14)
Weak Trend
14.61
UO(9)
Bearish
51.35
ROC(12)
Uptrend And Accelerating
7.36
WillR(14)
Neutral
-64.18
Bearish
2
Neutral
5
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Price & Volume Screeners
Intraday Screeners
Fundamental Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.